Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Anthony R. Chase currently holds 1,318 shares of Sarepta Therapeutics, Inc. (SRPT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Anthony R. Chase has been a net seller of SRPT stock. They have purchased $2.0M and sold $2.9M worth of shares.
Anthony R. Chase's most recent insider trade was on Oct 5, 2024, when they sold 1,318 shares at $0.00 per share.
Anthony R. Chase serves as Executive at Sarepta Therapeutics, Inc. (SRPT). They have executed 180 insider transactions totaling $4.9M over their tenure at the company.
Anthony R. Chase holds the position of Executive at Sarepta Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Anthony R. Chase has shown a selling trading pattern, with $2.0M in total purchases and $2.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Anthony R. Chase was on May 18, 2017, when they purchased $100.0K worth of APC shares. This transaction involved 1,905 shares at $52.48 per share.
Anthony R. Chase currently owns 1,318 shares of Sarepta Therapeutics, Inc. (SRPT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Anthony R. Chase's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Anthony R. Chase has 180 Form 4 filings on record as an insider at Sarepta Therapeutics, Inc..
Set alerts for Anthony R. Chase and 40,000+ other insiders.